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Trihalomethanes (THMs), such as chloro-
form, are chlorination by-products of drink-
ing water resulting from the reaction of
chlorine with organic material in the water.
THMs have been found to be associated
with tumors in animal studies (1). In addi-
tion, epidemiologic studies in adults poten-
tially exposed to THMs have shown excesses
of colon, rectum, and bladder cancer (1).
Most environmental chemicals must be
biotransformed to have toxic effects. This bio-
transformation is a two-stage process carried
out by phase I and phase II metabolizing
enzymes (2). Phase I enzymes such as those
belonging to the cytochrome P-450 (CYP)
family are involved in the initial oxidation,
reduction, or dealkylation of carcinogens; this
phase generally leads to the production of
active intermediate metabolites. Phase II
enzymes such as those belonging to the glu-
tathione S-transferase (GST) family convert
the active metabolites produced during phase I
reactions into water-soluble and excretable
products. Individual variation in the genes
encoding these enzymes could modify the
effects associated with speciﬁc exposures and
thus influence susceptibilities to cancer,
including childhood leukemia (3). Recent
studies have shown that the enzymes CYP2E1
and GSTT1 are involved in the metabolism of
THM, the latter in particular with brominated
THM (4–6). Therefore, studying whether the
risk for cancer associated with exposure to
THMs in drinking water is modified by
polymorphisms in the genes encoding these
particular enzymes would seem relevant.
We recently performed a case–control
study investigating the risk for acute lym-
phoblastic leukemia (ALL) associated with
exposure to THMs in drinking water in chil-
dren 0–9 years old (7). We studied the risk
for ALL from exposure to THMs during the
prenatal and the postnatal periods and found
that odds ratios (ORs) were generally not
increased for the prenatal period and when
using average levels of exposure. However,
postnatal cumulative exposure for total
THM above the 95th percentile of the dis-
tribution for cases and controls was associ-
ated with an OR of 1.54 [95% confidence
interval (95% CI) = 0.78–3.03]; for that
same period, risk associated with exposure to
chloroform was increased (OR = 1.63; 95%
CI, 0.84–3.19). To clarify further whether
risk for ALL in these children was modiﬁed
by DNA variants in the genes encoding
enzymes involved in the metabolism of
THM such as chloroform, we performed a
case-only study on a subset of the cases
selected for the original case–control study.
Materials and Methods
Case–control study. Details of the case–con-
trol study are provided elsewhere (7). In
brief, we recruited patients with ALL
between 0 and 9 years old diagnosed
between 1980 and 1993 in the Province of
Québec from tertiary care centers designated
by governmental policy to hospitalize and
treat children with cancer in the province.
Tracing cases from these hospitals is equiva-
lent to population-based ascertainment. We
selected controls for these cases from family
allowance files and matched them to each
patient for age, sex, and region of residence
(we based the deﬁnition of these regions on
administrative and geographical criteria, and
they cover wide territories). The family
allowance is a government stipend awarded
to all families with children living legally in
Canada and was the most complete census
of children available for the study years.
Participation rates were 96.3% among cases
and 83.8% among controls. We analyzed
491 cases and 491 controls. The ethical
review board of each participating hospital
approved the project for recruitment of
cases, whereas that for controls was approved
by the provincial paragovernmental agency
regulating access to databases with personal
identiﬁers.
Sources of data for exposure measure-
ment and exposure matrix. Extensive details
on the exposure assessment method are
given in (7). Brieﬂy, to determine exposure
to THMs in drinking water, we developed a
municipality-exposure matrix. To do so, we
used a) information from interview of par-
ents where child’s residential history covering
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The purpose of the study was to determine whether the risk of childhood acute lymphoblastic
leukemia (ALL) associated with drinking water disinfection by-products was modiﬁed in the pres-
ence of variants in genes involved in the metabolism of trihalomethanes (THMs). We included a
subset of cases from a population-based case–control study in a case-only study to estimate the
interaction odds ratios (IORs) between prenatal and postnatal exposure to THMs and polymor-
phisms in the GSTT1 and CYP2E1 genes. We compared cases with and without a given variant
regarding their exposure to THMs using unconditional logistic regression. The IOR for a postna-
tal average of total THM above the 95th percentile with GSTT1 null genotype was 9.1 [95%
conﬁdence interval (95% CI), 1.4–57.8]. With CYP2E1 (variant G-1259C, known as the allele
CYP2E1*5), the effect of exposure during pregnancy for an average exposure to total THM at or
above the 75th percentile was 9.7 (95% CI, 1.1–86.0). These results contrast strongly with those
from our case–control analysis, in which we considered the exposure to THMs only in relation
with ALL, and observed no increase in risk or very moderate ones. The present preliminary study
shows suggestive but imprecise results. We found no similar results in the literature, underscoring
the need for other studies as well as the potential usefulness of combining exposure and relevant
genetic information in such studies. Key words: childhood leukemia, CYP2E1, disinfection by-
products, drinking water, genetic polymorphisms, GSTT1, trihalomethanes. Environ Health
Perspect 110:591–593 (2002). [Online 25 April 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p591-593infante-rivard/abstract.htmlthe pregnancy period up to the time reference
date was collected, b) historical data provided
by municipalities and the ministry of environ-
ment, and c) a tap water survey carried out in
227 homes. We used all these sources of data
to fill the cells of the matrix, which we
defined by rows of municipalities and
columns of specific contaminants; a third
dimension was the calendar year. For cells
with a missing value, we imputed the closest
available annual average measurement (before
or after a missing year). For the prenatal
period, 21% of person-years of exposure had
their value assigned from the current year
(i.e., no imputation), whereas 52% of person-
years of exposure were assigned from the near-
est 6 years or less. For the postnatal period,
these ﬁgures were 26% and 61%, respectively.
In the end, some data were available on
THMs for 436 of cases and 422 controls dur-
ing the prenatal period, and for 457 cases and
441 controls during the postnatal period.
We used three exposure indices in the
analysis. A ﬁrst index was, over the exposure
period, whether drinking water was never
chlorinated, chlorinated part of the time, or
always chlorinated. A second index was the
average level of exposure over the period
[∑(concentrationj × durationi in days) ÷
total duration]; we then categorized it at
> 95% percentile of the distribution for cases
and controls. We also categorized the aver-
age level into three categories: ≤ 24th per-
centile, 25th to 74th percentile, and ≥ 75th
percentile. A third index was the cumulative
weighted sum over the exposure period
[∑(concentrationj × durationi in days)],
which we then categorized as above. In the
present report we use the second and third
indices of exposure.
Case-only study. The case-only study has
been recently proposed as an efﬁcient design
for studying gene–environment interactions
(8). Based only on cases, the OR measuring
the association between the gene of interest
and the particular environmental exposure
among these cases is a measure of the inter-
action parameter. The latter is an efficient
estimate of the interaction odds ratio (IOR)
one would obtain from the case–control
study and is a valid estimate of this quantity
if the exposure and the genotype in the pop-
ulation are independent (9).
For this study, we used 170 cases from
the set of 491 cases; these came from the
largest pediatric cancer-treating center in the
province where genotyping of all ALL cases
has been systematically initiated. All parents
signed a consent form for our use of DNA
material that was already provided for diag-
nostic and therapeutic purposes. The cases
included here are all of French-Canadian
origin (French-Canadians make up about
80% of the population in the Province of
Québec). The polymorphic deletion in the
GSTT1 gene was revealed by a polymerase
chain reaction (PCR)-based assay using
internal controls (10). PCR allele-specific
oligonucleotide hybridization assays have
been used to genotype the polymorphism G-
1259C (a G-to-C substitution at position
–1259 in the promoter) that defines the
allele CYP2E1*5 (11).
Statistical analysis. We used uncondi-
tional logistic regression to estimate the
IORs and their 95% confidence intervals.
The IOR is deﬁned as 
ORge/(ORg × ORe) × Z, 
where g stands for genotype, e for exposure,
and Z for the OR between exposure and
genotype in the controls, assumed to be 1
based on the independence assumption.
Results
Among the 170 genotyped cases, 161 cases
also had exposure data. We compared the
age and sex distributions (conﬁrmed risk fac-
tors for ALL) of the 161 genotyped subjects
entering the analysis with those of the entire
set of cases and found that 57% were boys in
comparison with 56% among all 491 cases,
and 58% were < 5 years old in comparison
with 66% among all cases.
In the present study, we analyzed the
GSTT1 polymorphism with the index mea-
suring average as well as the cumulative level
of exposure for total THM > 95th percentile
and likewise for bromoform at ≥ 75th per-
centile; for CYP2E1*5, we used the average
as well as the cumulative level at ≥ 75th per-
centile. We based the percentile distributions
on the complete set of subjects, as previously
described, but for some situations in the pre-
sent analysis we had too few subjects > 95th
percentile to use that category; instead, we
used a broader category (≥ 75th percentile).
To evaluate latency, we determined average
and cumulative exposure for the period
ranging from pregnancy to 1 year before
diagnosis or reference date for controls. For
Children’s Health • Infante-Rivard et al.
592 VOLUME 110 | NUMBER 6 | June 2002 • Environmental Health Perspectives
Table 1. IORs and 95% CIs for exposure to THMs and GSTT1 and CYP2E1 genotypes among children with
ALL.
Prenatal Postnatal
Gene/exposure IOR (95% CI) IOR (95% CI)
GSTT1 null (23 M; 131 N) (25 M; 136 N)
Total THM (> 95th percentile)
Average 2.40 (0.43–13.18) 9.13 (1.44–57.82)
Cumulative 2.40 (0.43–13.18) 2.51 (0.60–10.45)
Average for complete perioda 4.6 (0.96–21.97) —
Cumulative for complete perioda 2.23 (0.55–9.06) —
Bromoformb (≥ 75th percentile)
Average — 0.53 (0.17–1.52)
Cumulative — 0.57 (0.18–1.64)
Average for complete perioda 0.37 (0.10–1.33) —
Cumulative for complete perioda 0.39 (0.11–1.38) —
CYP2E1*5 (12 M; 118 N) (12 M; 125 N)
Total THM
Average
25th–74th percentile 3.50 (0.40–31.54) 1.61 (0.28–9.25)
≥ 75th percentile 9.75 (1.10–86.01) 4.06 (0.76–21.50)
For complete perioda
25th–74th percentile 1.56 (0.27–8.94) —
≥ 75th percentile 4.30 (0.81–22.77) —
Cumulative
25th–74th percentile 4.5 (0.52–39.12) 3.89 (0.45–33.67)
≥ 75th percentile 8.0 (0.88–72.51) 5.96 (0.66–53.82)
For complete perioda
25th–74th percentile 1.74 (0.32–9.43) —
≥ 75th percentile 2.95 (0.53–16.24) —
Chloroform
Average
25th–74th percentile 3.48 (0.40–30.97) 3.80 (0.42–33.75)
≥ 75th percentile 10.17 (1.15–89.89) 8.20 (0.94–71.72)
For complete perioda
25th–74th percentile 3.33 (0.37–29.60) —
≥ 75th percentile 8.57 (0.97–75.17) —
Cumulative
25th–74th percentile 4.60 (0.53–39.88) 5.47 (0.65–121.36)
≥ 75th percentile 7.69 (0.85–69.63) 7.31 (0.79–169.76)
For complete perioda
25th–74th percentile 3.33 (0.37–29.60) —
≥ 75th percentile 6.91 (0.79–60.37) —
Abbreviations: M, mutant allele (GSTT1 null genotype, carrier of at least one CYP2E1*5 allele); N, normal allele. 
aFrom pregnancy to the year before diagnosis. bAll subjects were in the ≥ 75th percentile category during pregnancy.study subjects younger than 1 year old, we
did not apply the latency period; four cases
were in this category in the present analysis.
Table 1 shows that the IOR was increased
with the GSTT1 null genotype in the postna-
tal period using the average level of total
THM and likewise for the complete period.
Using the cumulative THM level, risks were
only moderately increased and all conﬁdence
intervals included the null value. Results with
the average as well as the cumulative values
for bromoform suggested a nonsignificant
protective effect associated with the null
genotype. IORs were increased with the
CYP2E1*5 allele using the average or the
cumulative level for total THM and for chlo-
roform; risks were generally comparable for
the pregnancy and the postnatal period.
Discussion
Using the case-only methodology, we
observed that risk for ALL associated with
exposure to total THM was elevated among
children homozygous for GSTT1 deletion
(null genotype) but below the null value with
exposure to bromoform; risks for those carry-
ing the CYP2E1 variant G-1259C (allele *5)
were elevated for exposure occurring during
the prenatal as well as the postnatal period.
Many of these observations were imprecise
because of the relatively small number of
genotyped subjects. The data are quite pre-
liminary and will need to be replicated before
any strong conclusion is reached. However,
we have established that carcinogenic risks
from exposure to environmental toxicants can
be modiﬁed by genetic risk factors such that
certain individuals are more or less susceptible
as a result of DNA variants in the genes
encoding xenobiotic metabolizing enzymes.
Because the tested variant in the regula-
tory region of the CYP2E1 gene is associated
with an increased transcriptional activity
(12), individuals with this polymorphism
would be expected to show enhanced metab-
olism of THM and chloroform that in turn
would result in more activated metabolites.
Similarly, individuals lacking GSTT1
enzyme activity (GSTT1 null genotype)
would be at higher risk because they are less
efﬁcient in converting these reactive interme-
diates into soluble products.
Studies investigating the risk of ALL
from exposure to chlorination by-products
in drinking water are scarce. To our knowl-
edge, no study has investigated the joint
contribution of DNA variants in xenobiotic
metabolizing enzymes and exposure to
THMs in the pathogenesis of ALL, and only
two other studies have evaluated the associa-
tion between leukemia and drinking water
contamination, both ecologic: one study
(13) reported an inverse relationship
between exposure to THMs and leukemia
for adults, and the other (14) observed no
relation for ALL and exposure to THMs.
The validity of the IORs obtained from
case-only studies rests on the assumption of
independence of exposure and genes in the
population, such that individuals with cer-
tain DNA variants are not more or less likely
to be exposed to environmental contami-
nants. We have no data to support the inde-
pendence assumption in our study, but lack
of independence would seem unlikely for
maternal exposure given unknown child
genotype and likewise for the child postna-
tally given the nature of the exposure.
The interpretation of the measures of
effects for candidate genes in an association
study must be made with caution because
alternative explanations need to be consid-
ered. Although the studied gene could be
involved in causing the disease, another
interpretation is that the candidate gene is
not itself causally involved but rather is in
linkage disequilibrium with (very close to) a
causal gene. A third possibility is that the
study is affected by a population structure
bias (15) whereby many ethnic subgroups
with different allelic distributions are pooled
in the analysis, a potential bias that can
affect case-only studies (9). The latter expla-
nation for our results is unlikely because all
genotyped cases were ethnically homoge-
neous. The possibility of linkage disequilib-
rium remains, and although we have no data
to address this possibility, these closely
linked genes, if any, must participate in or
inﬂuence the metabolism of THM.
In conclusion, although imprecise and
preliminary, our results indicate that individ-
ual susceptibility as determined by DNA
variants may play a role in the etiology of
ALL. When considering the risk of ALL
associated with exposure to drinking water
contaminants, our results were not very sug-
gestive (7); the present results, on the other
hand, if validated in future studies, highlight
the importance of considering genetic varia-
tion with exposure to contaminants to deter-
mine associations.
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